Biological Factors - Interleukin-10 PubMed MeSh Term

Overview

subject area of

• (+)-Naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitation  Journal Article
• A Single Bout of Fasting (24 h) Reduces Basal Cytokine Expression and Minimally Impacts the Sterile Inflammatory Response in the White Adipose Tissue of Normal Weight F344 Rats  Journal Article
• A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine  Journal Article
• Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy  Journal Article
• Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy  Journal Article
• Commensal Bacteria and MAMPs Are Necessary for Stress-Induced Increases in IL-1β and IL-18 but Not IL-6, IL-10 or MCP-1  Journal Article
• Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10  Journal Article
• Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10  Journal Article
• Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice  Journal Article
• Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice  Journal Article
• Differential effects of neonatal handling on early life infection-induced alterations in cognition in adulthood  Journal Article
• Exosomes in fetal bovine serum dampen primary macrophage IL-1β response to lipopolysaccharide (LPS) challenge  Journal Article
• Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats  Journal Article
• IL-10 as a mediator in the HPA axis and brain  Journal Article
• INTERLEUKIN-10 (CYTOKINE SYNTHESIS INHIBITORY FACTOR) ACTS IN THE CENTRAL-NERVOUS-SYSTEM OF RATS TO REDUCE SLEEP  Journal Article
• Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain  Journal Article
• Immunotherapy with injectable hydrogels to treat obstructive nephropathy  Journal Article
• Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance  Journal Article
• Injectable Supramolecular Hydrogel/Microgel Composites for Therapeutic Delivery  Journal Article
• Intrathecal Injection of Naked Plasmid DNA Provides Long-term Expression of Secreted Proteins  Journal Article
• Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats  Journal Article
• Intrathecal non-viral interleukin-10 gene therapy ameliorates neuropathic pain as measured by both classical static allodynia and a novel supra-spinally mediated pain assay, the Two-Arm Rodent Somatosensory (TARS) task  Journal Article
• Local immunotherapy via delivery of interleukin-10 and transforming growth factor β antagonist for treatment of chronic kidney disease  Journal Article
• Long-term control of neuropathic pain in a non-viral gene therapy paradigm  Journal Article
• Microglia inflammatory responses are controlled by an intrinsic circadian clock  Journal Article
• Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats  Journal Article
• PEGylation of interleukin-10 for the mitigation of enhanced pain states  Journal Article
• PRESENCE OF INTERLEUKIN-10 TRANSCRIPTS IN HUMAN PITUITARY AND HYPOTHALAMUS  Journal Article
• Release of Plasmid DNA-Encoding IL-10 from PLGA Microparticles Facilitates Long-Term Reversal of Neuropathic Pain Following a Single Intrathecal Administration  Journal Article
• Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain  Journal Article
• Six weeks of voluntary wheel running modulates inflammatory protein (MCP-1, IL-6, and IL-10) and DAMP (Hsp72) responses to acute stress in white adipose tissue of lean rats  Journal Article
• Snake venom phospholipase A2s (Asp49 and Lys49) induce mechanical allodynia upon peri-sciatic administration: involvement of spinal cord glia, proinflammatory cytokines and nitric oxide  Journal Article
• Spinal Interleukin-10 Therapy to Treat Peripheral Neuropathic Pain  Journal Article
• Spinal cord glia and interleukin-1 do not appear to mediate persistent allodynia induced by intramuscular acidic saline in rats  Journal Article
• Strategies to reduce dendritic cell activation through functional biomaterial design  Journal Article
• Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A_2A receptor agonists  Journal Article
• Targeted interleukin-10 plasmid DNA therapy in the treatment of osteoarthritis: Toxicology and pain efficacy assessments  Journal Article
• The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure  Journal Article
• The therapeutic potential of interleukin-10 in neuroimmune diseases  Journal Article

broader concept

• Biological Factors - Interleukins  PubMed MeSh Term